SciClone Reports Second Quarter 2016 Financial Results

Go back to SciClone Reports Second Quarter 2016 Financial Results

Sciclone Pharma (SCLN) Reports Q2 EPS of $0.20

August 9, 2016 4:59 PM EDT

Sciclone Pharma (NASDAQ: SCLN) reported Q2 EPS of $0.20, versus $0.26 reported last year. Revenue for the quarter came in at $39 million, versus $37.9 million reported last year.

Outlook for 2016

SciClone projects its 2016 revenue to be in the range of $158 million... More